Nicole Perry - Jun 1, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Vice President - Accounting
Signature
/s/ David Watson, attorney-in-fact for Nicole Perry
Stock symbol
APLS
Transactions as of
Jun 1, 2021
Transactions value $
-$52,640
Form type
4
Date filed
6/2/2021, 04:15 PM
Next filing
Jun 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $3.76K +1K +20.63% $3.76* 5.85K Jun 1, 2021 Direct F1
transaction APLS Common Stock Sale -$56.4K -1K -17.1% $56.40 4.85K Jun 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -1K -10.92% $0.00 8.16K Jun 1, 2021 Common Stock 1K $3.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise from a 10B5-1 trading plan.
F2 This option was granted on July 31, 2015 and is fully vested.